Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Beta-Thalassemia
Related studies linked through entity extraction aliases.
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
- Status
- UNKNOWN
- Phase
- NA
Treatment of Iron Overload Requiring Chelation Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload
- Status
- TERMINATED
- Phase
- PHASE2
Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major
- Status
- COMPLETED
- Phase
- NA
Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload
- Status
- COMPLETED
- Phase
- PHASE2
Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia
- Status
- UNKNOWN
- Phase
- N/A
Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload
- Status
- COMPLETED
- Phase
- PHASE1
Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
- Status
- COMPLETED
- Phase
- PHASE4
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
- Status
- COMPLETED
- Phase
- PHASE4
Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major
- Status
- COMPLETED
- Phase
- NA
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
- Status
- COMPLETED
- Phase
- PHASE3
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
- Status
- TERMINATED
- Phase
- PHASE2
Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
- Status
- UNKNOWN
- Phase
- PHASE4
Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
- Status
- COMPLETED
- Phase
- PHASE2
Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions
- Status
- COMPLETED
- Phase
- PHASE3